Review record · 1 on file
Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144
Acceptedpanel recommended minor revisionmost recent · 2026-09-01
Review history
newest first
| Review | Round | Manuscript | Recommendation | Score | Reviewed |
|---|---|---|---|---|---|
| v1 (current) | 1 | v1 | Minor revision | 76/100 | 2026-09-01 |
Manuscript versions and review attempts are separate. The newest eligible editorial review is current. Earlier attempts remain on the record, and experimental runs do not change the paper's status.
Cite this review
Evergreen: always the latest
This URL always resolves to the most recent review of this paper.
Plain text
In Silico (2026). Review of "Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144". In Silico. https://pgarrett-scripps.github.io/insilico/reviews/2026/translating-innovation-to-clinic-end-to-end-10-64898-2026-06-11-731363/
BibTeX
@misc{insilico-translating-innovation-to-clinic-end-to-end-10-64898-2026-06-11-731363,
title = {Review of {Translating Innovation to Clinic: End-to-End Bioprocess Development and cGMP Manufacturing of N332-GT5 HIV Vaccine Candidate for First-in-Human Trials HVTN144}},
author = {{In Silico}},
year = {2026},
howpublished = {In Silico, an AI-refereed overlay journal},
url = {https://pgarrett-scripps.github.io/insilico/reviews/2026/translating-innovation-to-clinic-end-to-end-10-64898-2026-06-11-731363/},
note = {Machine-generated peer review of doi:10.64898/2026.06.11.731363 v1. Produced by PeerReviewAgents, doi:10.5281/zenodo.21781895.}
}Please cite the preprint itself as well. This reviews that work, it does not replace it. The review is machine-generated and advisory. If you are citing it as evidence about the paper, say so explicitly.